W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > February 2007

Re: [HCLSIG] ADDL review - Answer ADDL Questions?

From: kc28 <kei.cheung@yale.edu>
Date: Wed, 31 Jan 2007 22:27:41 -0500
To: June Kinoshita <junekino@media.mit.edu>
Cc: donald.doherty@brainstage.com, public-semweb-lifesci@w3.org
Message-id: <45C15E2D.2000001@yale.edu>

Hi June, Don, et al,

As part of the BioRDF's SenseLab task, we have recently created an RDFS 
ontology for BrainPharm (a subdatabase of SenseLab). The ontology can be 
used to model information about the effect of drugs on pathological (or 
molecular) mechanisms (which involve neuronal properties such as 
receptors, currents, and neurotransmitters) mediating the pathological 
changes in various neurological disorders such as AD. For more 
information, please go to the following wiki page:

http://esw.w3.org/topic/BrainPharm

I hope this ontology (with modifications/extensions perhaps) may be 
useful to the AD use case.

Best,

-Kei

June Kinoshita wrote:

>
> Thanks Don. I think we'll hunker down with the article for a while,  
> and if any questions come up, perhaps she could answer them via  
> email. That may be the most efficient way to proceed at this point.
>
> Cheers,
> June
>
> On Jan 31, 2007, at 2:48 PM, Donald Doherty wrote:
>
>>
>> Hi All,
>>
>> Susan Catalano said she'd be happy to join one of the HCLSIG  
>> teleconference
>> calls to answer questions about ADDL (if there is still a need).
>>
>> Don
>>
>> -----
>> Donald Doherty, Ph.D.
>> Brainstage Research, Inc.
>> www.brainstage.com
>> donald.doherty@brainstage.com
>> 412-683-1410
>>
>>
>>
>
>
Received on Thursday, 1 February 2007 03:30:04 GMT

This archive was generated by hypermail 2.3.1 : Tuesday, 26 March 2013 18:00:46 GMT